Induction of HIV-1 Replication in Latently Infected CD4+ T Cells Using a Combination of Cytokines
暂无分享,去创建一个
Anthony S. Fauci | T. Chun | A. Fauci | L. Ehler | Tae-Wook Chun | Linda A. Ehler | Stephanie B. Mizell | S. Mizell | D. Engel | Delphine Engel
[1] J. Dayer,et al. Purified blood monocytes from HIV 1-infected patients induce high levels of TNFα and IL-1 , 1989 .
[2] A. Perelson,et al. HIV-1 Dynamics in Vivo: Virion Clearance Rate, Infected Cell Life-Span, and Viral Generation Time , 1996, Science.
[3] G. Nabel,et al. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[4] C. Boucher,et al. Overshoot of HIV‐1 viraemia after early discontinuation of antiretroviral treatment , 1997, AIDS.
[5] A. Fauci,et al. Interleukin 1 Induces HIV-1 Expression in Chronically Infected U1 Cells: Blockade by Interleukin 1 Receptor Antagonist and Tumor Necrosis Factor Binding Protein Type 1 , 1995, Molecular medicine.
[6] R. Puri,et al. Human Cytokines: Their Role in Disease and Therapy , 1995 .
[7] A. Fauci,et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. , 1994, Science.
[8] J. Justement,et al. Glucocorticoids synergize with tumor necrosis factor alpha in the induction of HIV expression from a chronically infected promonocytic cell line. , 1993, AIDS research and human retroviruses.
[9] A. Fauci,et al. Modulation of endogenous IL-1 beta and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. , 1996, Journal of immunology.
[10] S. Garbisa,et al. Spontaneous production of interleukin-6 by alveolar macrophages from human immunodeficiency virus type 1-infected patients. , 1992, The Journal of infectious diseases.
[11] E. De Clercq,et al. Tumor necrosis factor antagonizes inhibitory effect of azidothymidine on human immunodeficiency virus (HIV) replication in vitro. , 1990, Biochemical and biophysical research communications.
[12] Anthony S. Fauci,et al. Host factors and the pathogenesis of HIV-induced disease , 1996, Nature.
[13] Martin A. Nowak,et al. Viral dynamics in human immunodeficiency virus type 1 infection , 1995, Nature.
[14] P. Roux‐Lombard,et al. Purified blood monocytes from HIV 1-infected patients produce high levels of TNF alpha and IL-1. , 1989, Clinical immunology and immunopathology.
[15] M A Nowak,et al. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] A. Fauci,et al. Induction of HTLV-III/LAV from a nonvirus-producing T-cell line: implications for latency. , 1986, Science.
[17] R. Schleimer,et al. Glucocorticosteroid inhibition of cytokine production: relevance to antiallergic actions. , 1996, The Journal of allergy and clinical immunology.
[18] J. Justement,et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms , 1990, The Journal of experimental medicine.
[19] A. Fauci,et al. Cytokine Cascades in HIV Infection , 1996 .
[20] T. Olsson,et al. Increased mRNA expression of IL-6, IL-10, TNF-alpha, and perforin in blood mononuclear cells in human HIV infection. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.
[21] G. Zimmerman,et al. Endothelial cell interactions with granulocytes: tethering and signaling molecules. , 1992, Immunology today.
[22] A. Fauci,et al. HIV replication in IL-2-stimulated peripheral blood mononuclear cells is driven in an autocrine/paracrine manner by endogenous cytokines. , 1995, Journal of immunology.
[23] N. Yamamoto,et al. Effect of interleukin-1 on the augmentation of human immunodeficiency virus gene expression. , 1989, Biochemical and biophysical research communications.
[24] J. Justement,et al. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. , 1987, Science.
[25] L. McQuay,et al. Dilution assay statistics , 1994, Journal of clinical microbiology.
[26] D. Richman,et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. , 1997, Science.
[27] A. Hernvann,et al. Differential elevation of circulating interleukin-1 beta, tumor necrosis factor alpha, and interleukin-6 in AIDS-associated cachectic states , 1994, Clinical and diagnostic laboratory immunology.
[28] T. Elbeik,et al. Activation of virus replication after vaccination of HIV-1-infected individuals , 1995, The Journal of experimental medicine.
[29] A. Fauci,et al. Cytokine modulation of HIV expression. , 1993, Seminars in immunology.
[30] M. Rieder,et al. Regulation of cytokine and cytokine receptor expression by glucocorticoids , 1996, Journal of leukocyte biology.
[31] A. Fauci,et al. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. , 1993, Science.
[32] A. Fauci,et al. Mechanisms of glucocorticoid action on immune processes. , 1979, Annual review of pharmacology and toxicology.
[33] A. Fauci,et al. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[34] G. Chrousos,et al. The Stress Response and the Regulation of Inflammatory Disease , 1992, Annals of Internal Medicine.
[35] A. Fauci,et al. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells? , 1994, Journal of virology.
[36] M. Ostrowski,et al. Increased in vitro tetanus-induced production of HIV type 1 following in vivo immunization of HIV type 1-infected individuals with tetanus toxoid. , 1997, AIDS Research and Human Retroviruses.
[37] A. Fauci,et al. New concepts in the immunopathogenesis of HIV infection. , 1995, Annual review of immunology.
[38] W. O'brien,et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. , 1995, Blood.
[39] W. Paul,et al. Lymphocyte responses and cytokines , 1994, Cell.
[40] C H Fox,et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. , 1996, The New England journal of medicine.
[41] R. Siliciano,et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection , 1997, Nature.
[42] D. Dormont,et al. Treatment of human monocyte-derived macrophages with a TNF alpha synthesis inhibitor prior to HIV1 infection: consequences on cytokine production and viral replication. , 1994, Research in virology.
[43] A. Baldwin,et al. Role of Transcriptional Activation of IκBα in Mediation of Immunosuppression by Glucocorticoids , 1995, Science.
[44] A. Capron,et al. Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. , 1989, Clinical and experimental immunology.
[45] A. Baldwin,et al. Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. , 1995, Science.
[46] L. Montaner,et al. Tumor necrosis factor alpha inhibits entry of human immunodeficiency virus type 1 into primary human macrophages: a selective role for the 75-kilodalton receptor , 1996, Journal of virology.
[47] R Brookmeyer,et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. , 1997, Science.
[48] A. Perelson,et al. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection , 1995, Nature.